The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished. In a […] Continue reading ->
Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading ->
The recent hantavirus outbreak triggered a wave of disinformation along similar lines to the COVID-19 pandemic: the virus was “fake”, “deliberately engineered”, and could be “cured” by Ivermectin. In the past week, furious community members have attacked and torched tents housing Ebola patients at Mongbwalu General Referral Hospital in the Democratic Republic of Congo (DRC) […] Continue reading ->
The World Health Organization’s (WHO) Director General has called for an immediate ceasefire in the eastern DRC to enable officials to address the outbreak of a particularly deadly strain of Ebola, warning that stopping transmission “depends entirely on humanitarian access”. The DRC’s Ituri province, the heart of the Ebola Bundibugyo virus outbreak, is facing “a […] Continue reading ->
Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading ->
The growing impact of climate change on respiratory health, including through longer pollen seasons, wildfires and more exterme heat, was the focus of an high-level event on the margins of the 79th World Health Assembly (WHA) in Geneva, organized by the Geneva Health Forum and Health Diplomacy Alliance. The event followed on the heels of a […] Continue reading ->
GENEVA — Hundreds of hours of formal negotiations and corridor-side bargaining in the halls of the United Nations (UN) Palais des Nations and World Health Organization (WHO) headquarters this week ended on Saturday afternoon – more or less on schedule, an outcome rare enough at the UN to be cause for celebration. The sunshine, Mont […] Continue reading ->
WHO Member States approved a new 10-year global action plan to combat antimicrobial resistance (AMR) on Friday after a months-long fight over how the world should share AMR-related medical technologies. The plan, which runs through 2036, maps out strategies for countries to implementing the ambitious targets set at a UN High Level Meeting, including reducing […] Continue reading ->
Sweeping personnel cuts and a massive emergency funding shortfall trigger sharp warnings about acute WHO operational risks from member states and experts. Yet, diverging regional priorities complicate short-term and sustainable financing solutions. GENEVA –Member states sounded alarms over severe WHO budget constraints on Thursday at the World Health Assembly. Delegates warned that a 9.4% staff […] Continue reading ->
Liver disease, social media harms and health taxes dominated the World Health Assembly’s (WHA) discussion on non-communicable diseases (NCDs) on Thursday. For the first time, countries resolved to include steatotic liver disease (SLD), which is closely linked to obesity and diabetes, into NCD plans. Formerly known as fatty liver disease, SLD affects an estimated 1.7 […] Continue reading ->